Solid Tumors and Hematologic Malignancy
Oncology·MeSH: Hematologic Neoplasms
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| incb059872 | Incyte Corp. (INCY) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| all-trans retinoic acid | Incyte Corp. (INCY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Solid Tumors and Hematologic Malignancy?
BioSniper tracks 2 drugs in development for Solid Tumors and Hematologic Malignancy across 1 company.
How many clinical trials target Solid Tumors and Hematologic Malignancy?
There are 1 clinical trial targeting Solid Tumors and Hematologic Malignancy tracked by BioSniper.
Deep-dive into Solid Tumors and Hematologic Malignancy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis